Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 6 » default
ClinicoEconomics and Outcomes Research
- View all (626)
- Volume 12, 2020 (67)
- Volume 11, 2019 (71)
- Volume 10, 2018 (77)
- Volume 9, 2017 (77)
- Volume 8, 2016 (73)
- Volume 7, 2015 (64)
- Volume 6, 2014 (53)
- Volume 5, 2013 (59)
- Volume 4, 2012 (41)
- Volume 3, 2011 (19)
- Volume 2, 2010 (16)
- Volume 1, 2009 (9)
Archive: Volume 6, 2014
Effect of occasional epoetin use in combination with a stable darbepoetin dosage on anemia management in hemodialysis patients
Shimamatsu K
ClinicoEconomics and Outcomes Research 2014, 6:531-535
Published Date: 9 December 2014
Different strategies and cost-effectiveness in the treatment of primary open angle glaucoma
Ting NSJ, Li Yim JFT, Ng JY
ClinicoEconomics and Outcomes Research 2014, 6:523-530
Published Date: 4 December 2014
Level, pattern, and determinants of polypharmacy and inappropriate use of medications by village doctors in a rural area of Bangladesh
Rasu RS, Iqbal M, Hanifi SMA, Moula A, Hoque S, Rasheed S, Bhuiya A
ClinicoEconomics and Outcomes Research 2014, 6:515-521
Published Date: 3 December 2014
Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization
Perrone V, Conti V, Venegoni M, Scotto S, Degli Esposti L, Sangiorgi D, Prestini L, Radice S, Clementi E, Vighi G
ClinicoEconomics and Outcomes Research 2014, 6:505-514
Published Date: 3 December 2014
Measurement properties of painDETECT by average pain severity
Cappelleri JC, Bienen EJ, Koduru V, Sadosky A
ClinicoEconomics and Outcomes Research 2014, 6:497-504
Published Date: 6 November 2014
Pain severity and the economic burden of neuropathic pain in the United States: BEAT Neuropathic Pain Observational Study
Schaefer C, Sadosky A, Mann R, Daniel S, Parsons B, Tuchman M, Anschel A, Stacey BR, Nalamachu S, Nieshoff E
ClinicoEconomics and Outcomes Research 2014, 6:483-496
Published Date: 29 October 2014
Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia
Shafie AA, Lim YW, Chua GN, Hassali MA
ClinicoEconomics and Outcomes Research 2014, 6:473-481
Published Date: 23 October 2014
Clinical outcomes and health care costs combining metformin with sitagliptin or sulphonylureas or thiazolidinediones in uncontrolled type 2 diabetes patients
Degli Esposti L, Saragoni S, Buda S, Degli Esposti E
ClinicoEconomics and Outcomes Research 2014, 6:463-472
Published Date: 21 October 2014
Clinical response and hospital costs associated with the empirical use of vancomycin and linezolid for hospital-acquired pneumonia in a Chinese tertiary care hospital: a retrospective cohort study
Song Y, Yang Y, Chen W, Liu W, Wang K, Li X, Wang K, Papadimitropoulos M, Montgomery W
ClinicoEconomics and Outcomes Research 2014, 6:451-461
Published Date: 17 October 2014
Economic burden of asthma in Abu Dhabi: a retrospective study
Alzaabi A, Alseiari M, Mahboub B
ClinicoEconomics and Outcomes Research 2014, 6:445-450
Published Date: 17 October 2014
A medicoeconomic review of early intervention with biologic agents in the treatment of inflammatory bowel diseases
Odes S, Greenberg D
ClinicoEconomics and Outcomes Research 2014, 6:431-443
Published Date: 8 October 2014
Retrospective database analysis of clinical outcomes and costs for treatment of abnormal uterine bleeding among women enrolled in US Medicaid programs
Bonafede MM, Miller JD, Laughlin-Tommaso SK, Lukes AS, Meyer NM, Lenhart GM
ClinicoEconomics and Outcomes Research 2014, 6:423-429
Published Date: 8 October 2014
Laparoscopic versus open colorectal resection for cancer and polyps: a cost-effectiveness study
Jordan J, Dowson H, Gage H, Jackson D, Rockall T
ClinicoEconomics and Outcomes Research 2014, 6:415-422
Published Date: 26 September 2014
Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service
Restelli U, Andreoni M, Antinori A, Bonfanti M, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Croce D
ClinicoEconomics and Outcomes Research 2014, 6:409-414
Published Date: 23 September 2014
Adherence and resource use among patients treated with biologic drugs: findings from BEETLE study
Degli Esposti L, Sangiorgi D, Perrone V, Radice S, Clementi E, Perone F, Buda S
ClinicoEconomics and Outcomes Research 2014, 6:401-407
Published Date: 18 September 2014
Impact of potential pregabalin or duloxetine drug–drug interactions on health care costs and utilization among Medicare members with fibromyalgia
Ellis JJ, Sadosky AB, Ten Eyck LL, Cappelleri JC, Brown CR, Suehs BT, Parsons B
ClinicoEconomics and Outcomes Research 2014, 6:389-399
Published Date: 14 October 2014
Cost of tumor necrosis factor blockers per patient with rheumatoid arthritis in a multistate Medicaid population
Bonafede M, Joseph GJ, Shah N, Princic N, Harrison DJ
ClinicoEconomics and Outcomes Research 2014, 6:381-388
Published Date: 15 September 2014
Economic burden associated with chronic constipation in Sweden: a retrospective cohort study
Bruce Wirta S, Hodgkins P, Joseph A
ClinicoEconomics and Outcomes Research 2014, 6:369-379
Published Date: 12 August 2014
Oncology drug health technology assessment recommendations: Canadian versus UK experiences
Chabot I, Rocchi A
ClinicoEconomics and Outcomes Research 2014, 6:357-367
Published Date: 16 July 2014
Costs and health care resource utilization among chronic obstructive pulmonary disease patients with newly acquired pneumonia
Lin J, Li Y, Tian H, Goodman MJ, Gabriel S, Nazareth T, Turner SJ, Arcona S, Kahler KH
ClinicoEconomics and Outcomes Research 2014, 6:349-356
Published Date: 16 July 2014
Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients
Perrone V, Cattaneo D, Radice S, Sangiorgi D, Federici AB, Gismondo MR, Medaglia M, Micheli V, Vimercati S, Pallone E, Degli Esposti L, Clementi E
ClinicoEconomics and Outcomes Research 2014, 6:341-348
Published Date: 14 July 2014
Considerations for payers in managing hormone receptor-positive advanced breast cancer
Chitre M, Reimers KM
ClinicoEconomics and Outcomes Research 2014, 6:331-339
Published Date: 10 July 2014
Cost-effectiveness of continuous erythropoietin receptor activator in anemia
Schmid H
ClinicoEconomics and Outcomes Research 2014, 6:319-330
Published Date: 3 July 2014
Cost of opioid intravenous patient-controlled analgesia: results from a hospital database analysis and literature assessment
Palmer P, Ji X, Stephens J
ClinicoEconomics and Outcomes Research 2014, 6:311-318
Published Date: 20 June 2014
Health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy
Mennini FS, Marcellusi A, Andreoni M, Gasbarrini A, Salomone S, Craxì A
ClinicoEconomics and Outcomes Research 2014, 6:303-310
Published Date: 19 June 2014
Economic impact of infections among patients with primary immunodeficiency disease receiving IVIG therapy
Menzin J, Sussman M, Munsell M, Zbrozek A
ClinicoEconomics and Outcomes Research 2014, 6:297-302
Published Date: 10 June 2014
Comparison of the costs of nonoperative care to minimally invasive surgery for sacroiliac joint disruption and degenerative sacroiliitis in a United States commercial payer population: potential economic implications of a new minimally invasive technology
Ackerman SJ, Polly Jr DW, Knight T, Schneider K, Holt T, Cummings Jr J
ClinicoEconomics and Outcomes Research 2014, 6:283-296
Published Date: 24 May 2014
Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review
Coyne KS, LoCasale RJ, Datto CJ, Sexton CC, Yeomans K, Tack J
ClinicoEconomics and Outcomes Research 2014, 6:269-281
Published Date: 23 May 2014
Conversion of the Seattle Angina Questionnaire into EQ-5D utilities for ischemic heart disease: a systematic review and catalog of the literature
Wijeysundera HC, Farshchi-Zarabi S, Witteman W, Bennell MC
ClinicoEconomics and Outcomes Research 2014, 6:253-268
Published Date: 19 May 2014
Health economics evidence for medical nutrition: are these interventions value for money in integrated care?
Walzer S, Droeschel D, Nuijten M, Chevrou-Séverac H
ClinicoEconomics and Outcomes Research 2014, 6:241-252
Published Date: 19 May 2014
Dressing-related trauma: clinical sequelae and resource utilization in a UK setting
Charlesworth B, Pilling C, Chadwick P, Butcher M
ClinicoEconomics and Outcomes Research 2014, 6:227-239
Published Date: 28 April 2014
Respiratory syncytial virus: current and emerging treatment options
Turner TL, Kopp BT, Paul G, Landgrave LC, Hayes D Jr, Thompson R
ClinicoEconomics and Outcomes Research 2014, 6:217-225
Published Date: 25 April 2014
Drug adherence to olmesartan/amlodipine fixed combination in an Italian clinical practice setting
Degli Esposti L, Saragoni S, Buda S, Degli Esposti E
ClinicoEconomics and Outcomes Research 2014, 6:209-216
Published Date: 22 April 2014
Group-based trajectory modeling to assess adherence to biologics among patients with psoriasis
Li Y, Zhou H, Cai B, Kahler KH, Tian H, Gabriel S, Arcona S
ClinicoEconomics and Outcomes Research 2014, 6:197-208
Published Date: 10 April 2014
Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax®) in children
Ronaldson S, Taylor M, Bech PG, Shenton R, Bufe A
ClinicoEconomics and Outcomes Research 2014, 6:187-196
Published Date: 8 April 2014
Economic evaluation of aclidinium bromide in the management of moderate to severe COPD: an analysis over 5 years
Karabis A, Mocarski M, Eijgelshoven I, Bergman G
ClinicoEconomics and Outcomes Research 2014, 6:175-185
Published Date: 5 April 2014
Economic burden of torture for a refugee host country: development of a model and presentation of a country case study
Mpinga EK, Frey C, Chastonay P
ClinicoEconomics and Outcomes Research 2014, 6:165-173
Published Date: 2 April 2014
Economic and humanistic burden of illness in generalized anxiety disorder: an analysis of patient survey data in Europe
Toghanian S, DiBonaventura M, Järbrink K, Locklear JC
ClinicoEconomics and Outcomes Research 2014, 6:151-163
Published Date: 2 April 2014
Economic implications of using bendamustine, alemtuzumab, or chlorambucil as a first-line therapy for chronic lymphocytic leukemia in the US: a cost-effectiveness analysis
Kongnakorn T, Sterchele JA, Salvador CG, Getsios D, Mwamburi M
ClinicoEconomics and Outcomes Research 2014, 6:141-149
Published Date: 1 April 2014
Cost-effectiveness analysis of orbital atherectomy plus balloon angioplasty vs balloon angioplasty alone in subjects with calcified femoropopliteal lesions
Weinstock B, Dattilo R, Diage T
ClinicoEconomics and Outcomes Research 2014, 6:133-139
Published Date: 19 March 2014
Comparative cost effectiveness of Coflex® interlaminar stabilization versus instrumented posterolateral lumbar fusion for the treatment of lumbar spinal stenosis and spondylolisthesis
Schmier JK, Halevi M, Maislin G, Ong K
ClinicoEconomics and Outcomes Research 2014, 6:125-131
Published Date: 18 March 2014
Health economic analyses in medical nutrition: a systematic literature review
Walzer S, Droeschel D, Nuijten M, Chevrou-Séverac H
ClinicoEconomics and Outcomes Research 2014, 6:109-124
Published Date: 10 March 2014
The cost of antiretroviral treatment service for patients with HIV/AIDS in a central outpatient clinic in Vietnam
Nguyen LT, Tran BX, Tran CT, Le HT, Tran SV
ClinicoEconomics and Outcomes Research 2014, 6:101-108
Published Date: 21 February 2014
Predictors of biologic treatment of psoriasis: a non-interventional study
Puig L, Fan T, Ding Q, Smith NE
ClinicoEconomics and Outcomes Research 2014, 6:93-100
Published Date: 17 February 2014
Antibiotic expected effectiveness and cost under real life microbiology: evaluation of ertapenem and ceftriaxone in the treatment of community-acquired pneumonia for elderly patients in Spain
Grau S, Lozano V, Valladares A, Cavanillas R, Xie Y, Nocea G
ClinicoEconomics and Outcomes Research 2014, 6:83-92
Published Date: 13 February 2014
Duloxetine treatment adherence across mental health and chronic pain conditions
Able SL, Cui Z, Shen W
ClinicoEconomics and Outcomes Research 2014, 6:75-81
Published Date: 11 February 2014
Management of sacroiliac joint disruption and degenerative sacroiliitis with nonoperative care is medical resource-intensive and costly in a United States commercial payer population
Ackerman SJ, Polly Jr DW, Knight T, Holt T, Cummings J
ClinicoEconomics and Outcomes Research 2014, 6:63-74
Published Date: 11 February 2014
Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
Grima DT, Brown ST, Kamboj L, Bainey KR, Goeree R, Oh P, Ramanathan K, Goodman SG
ClinicoEconomics and Outcomes Research 2014, 6:49-62
Published Date: 24 January 2014
Cost-effectiveness analysis of Mammostrat® compared with Oncotype DX® to inform the treatment of breast cancer
Mislick K, Schonfeld W, Bodnar C, Tong KB
ClinicoEconomics and Outcomes Research 2014, 6:37-47
Published Date: 16 January 2014
Out-of-pocket cost of managing sick newborns in Enugu, southeast Nigeria
Ekwochi U, Osuorah DC, Ndu IK, Ezenwosu OU, Amadi OF, Nwokoye IC, Odetunde OI
ClinicoEconomics and Outcomes Research 2014, 6:29-35
Published Date: 16 January 2014
Estimation of utility values from visual analog scale measures of health in patients undergoing cardiac surgery
Oddershede L, Andreasen JJ, Ehlers L
ClinicoEconomics and Outcomes Research 2014, 6:21-27
Published Date: 10 January 2014
Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US
Bonafede MM, Johnson BH, Watson C
ClinicoEconomics and Outcomes Research 2014, 6:11-20
Published Date: 19 December 2013
Budget impact analysis of the fentanyl buccal tablet for treatment of breakthrough cancer pain
Darbà J, Kaskens L, Sánchez-de la Rosa R
ClinicoEconomics and Outcomes Research 2014, 6:1-9
Published Date: 16 December 2013